Intrinsiqs

Is Inhibrx Biosciences Inc. overvalued?

Inhibrx Biosciences Inc. (INBX) — key valuation metrics and fundamentals.

No verdict
Price
$95.00
Fair value
Current P/E
Normal P/E
Market cap
$1.39B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares INBX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.